Aktsiaselts Medicum Tervishoiuteenused

At Aktsiaselts Medicum Tervishoiuteenused in Tallinn, research in cardiovascular diseases focuses on atherosclerotic cardiovascular disease and primary prevention in people at elevated risk. These studies are designed to evaluate whether new approaches can better reduce major heart and stroke events and improve long-term protection for patients.

• Preventing major adverse cardiovascular events in high-risk patients
• Studying treatment options for established atherosclerotic cardiovascular disease
• Testing ways to improve primary prevention of heart attacks and strokes

The site’s work in this area is centered on finding more effective strategies for lowering cardiovascular risk and supporting earlier intervention.

Clinical research in digestive system diseases includes studies in moderate to severe Crohn’s disease and ulcerative colitis. The main goal is to assess new therapies that may better control inflammation, improve symptoms, and offer more effective treatment options for adults living with chronic bowel disease.

• Evaluating targeted therapies for Crohn’s disease
• Comparing treatment options for active ulcerative colitis
• Assessing safety and effectiveness in inflammatory bowel disease care

This research supports ongoing efforts to improve disease control and quality of life for patients with long-term intestinal inflammation.

Studies in virus diseases at this hospital/clinic include work on herpes zoster and respiratory syncytial virus infections. The trials are focused on evaluating vaccines that may strengthen immune protection, reduce infection risk, and maintain response over time in older adults.

• Testing vaccine protection against herpes zoster
• Assessing immune response to respiratory syncytial virus vaccination
• Monitoring durability of vaccine-driven immune response

These studies aim to support better prevention of viral illness in populations that may be more vulnerable to complications.

Research in bacterial infections and mycoses includes studies of pneumococcal immunisation in infants, children, and adolescents. The trials are intended to examine vaccine safety and immune response, helping determine how well protection develops across different age groups.

• Evaluating the safety of pneumococcal vaccination
• Measuring immune response after vaccination in young children
• Supporting prevention of pneumococcal disease

This area reflects a strong focus on infection prevention through vaccination research at Aktsiaselts Medicum Tervishoiuteenused.

The site also contributes to research in immune system diseases, especially through studies that examine how the body responds to new medicines and vaccines. These trials help clarify safety, effectiveness, and immune activity in conditions where immune function plays a central role.

• Studying mechanistic profiles of targeted therapies
• Evaluating vaccine immunogenicity across age groups
• Exploring immune-based approaches to prevention and treatment

Overall, the research aims to advance both treatment and prevention strategies by better understanding immune responses.

In respiratory tract diseases, the clinical trials at this site include preventive research related to respiratory syncytial virus. The work is centered on determining whether vaccination can improve protection in older adults and support stronger immune defense against respiratory infection.

• Testing prevention strategies for respiratory syncytial virus infections
• Assessing the strength of vaccine-induced immunity
• Supporting research on respiratory infection prevention in older adults

This field highlights the site’s interest in reducing the burden of common viral respiratory illness through immunization research.